Birchview Capital, LP Novo Cure LTD Transaction History
Birchview Capital, LP
- $117 Million
- Q4 2024
A detailed history of Birchview Capital, LP transactions in Novo Cure LTD stock. As of the latest transaction made, Birchview Capital, LP holds 31,000 shares of NVCR stock, worth $482,980. This represents 0.79% of its overall portfolio holdings.
Number of Shares
31,000
Previous 20,000
55.0%
Holding current value
$482,980
Previous $312,000
195.83%
% of portfolio
0.79%
Previous 0.29%
Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
294Shares Held
75.8MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$189 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$184 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$138 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$75 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$42.7 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.64B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...